SunGen Pharma 製藥獲得美國 FDA 的第八個 ANDA 批准
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
新澤西州普林斯頓市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發，生產，和銷售製劑產品的製藥公司,今天宣布其已獲得美國食品與藥物管理局（FDA）的第八個ANDA文號批准。 第八個ANDA的產品名為利多卡因軟膏 5% (Lidocaine Ointment USP 5%), 每管規格為1.5盎司（35.44克）...
SunGen Pharma 制药获得美国 FDA 的第八个 ANDA 批准
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
新泽西州普林斯顿市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- 2019 年 10 月 31 日: SunGen Pharma, 一家私人控股的研发，生产，和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局（FDA）的第八个 ANDA文号批准。 第八个ANDA的产品名为利多卡因软膏 5% (Lidocaine Ointment USP 5%),...
SunGen Pharma Receives Eighth ANDA Approval from US FDA
October 31, 2019 13:51 ET
|
SunGen Pharma LLC
PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
January 03, 2019 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA
December 11, 2018 07:30 ET
|
SunGen Pharma LLC
PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma Receives US FDA Approval for Prednisone ANDA
December 10, 2018 12:28 ET
|
SunGen Pharma LLC
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
December 10, 2018 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
IntelGenx Reports Third Quarter 2018 Financial Results
November 08, 2018 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
Elite Pharmaceuticals Launches Generic Methadone Tablets
November 05, 2018 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
October 23, 2018 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...